Techniques
Foam phlebectomy
Large superficial varicosities create a practical problem. Ambulatory phlebectomy removes the vein, but finding and dissecting every branch can be time consuming. Ultrasound-guided foam sclerotherapy reaches a branching network through a needle, but the treated veins may remain palpable and tender, with retained blood and subsequent skin discoloration. A patient can undergo successful truncal ablation and still face several visits to deal with the tributaries.
I developed foam phlebectomy in the mid-2000s to combine the useful features of both procedures in one setting. Foam treats the superficial network and makes the veins conspicuous on ultrasound. Tumescent anesthesia provides local anesthesia and compresses the treated veins. Selected veins are then opened, decompressed and removed through small incisions. Ultrasound can guide the dissection when the vein is difficult to find.
The details matter: when the foam is injected, where the tumescent is placed, how the vein is engaged and how it is freed from the surrounding tissue. Combining two procedures is useful only if we understand what each contributes.
Why combine foam and phlebectomy
Varicose veins come in a large variety of presentations. The photographs below range from clusters of small, raised veins over the ankle and foot, through finer branching veins along the calf, to large bulging veins at the knee and thigh. They are treated primarily with ambulatory phlebectomy and ultrasound-guided foam sclerotherapy, and treatment is often staged over several visits. One instrument or one injection technique does not suit that whole range.
Both procedures are effective and safe. Each has its own strengths and drawbacks.
| Procedure | Strengths | Drawbacks |
|---|---|---|
| Ultrasound-guided foam sclerotherapy | Effective; safe; fast | Painful lumps; staining |
| Ambulatory phlebectomy | Effective; safe; no lumps | Time consuming; more discomfort; not all areas can be reached |
Ambulatory phlebectomy is particularly useful for large, bulging superficial varicosities. It removes the treated vein rather than leaving the entire segment to involute, which is why it leaves no lumps. Its limitations are the time required for dissection, procedural discomfort, and difficulty reaching some distributions or identifying small residual segments.
Foam is useful for smaller varicosities, branching networks and areas that are difficult to treat by phlebectomy. It is quick to distribute under ultrasound guidance. The tradeoff is that a vein containing retained blood after treatment may become a painful lump or develop overlying staining. Those findings can lead to an additional visit for microthrombectomy.
Foam phlebectomy brings these methods together. The larger accessible segments can be removed, while foam has already reached connected tributaries that may not be extracted. Foam can also treat communicating branch varicosities and perforators. The aim is to treat the range of superficial varicosities present in that patient, rather than require every branch to be suitable for one instrument or one treatment.
Most patients can then be treated in a single session, rather than over the staged visits described below. Follow-up still matters, and some patients need further treatment, as the experience later on this page records.
This still takes longer than foam sclerotherapy alone. At the time, combining procedures could be less favorable for reimbursement in the United States. That historical observation does not determine current billing or the clinical sequence.
Synchronous treatment and the evidence
In the staged pathway, the initial visit includes an ultrasound examination and is followed by three months of conservative management before endovenous ablation. The patient returns one week after the ablation for a review and an ultrasound, and again at three months for another review and ultrasound. Ambulatory phlebectomy follows. One month after the phlebectomy there is a further review, then ultrasound-guided foam sclerotherapy, and then a final visit. The concern was straightforward: too many clinic visits, too many separate procedures and too much time off work. Patients do not like it.
The AVULS randomized trial supports treating tributaries at the time of truncal ablation in appropriate patients. Among 101 patients, additional tributary treatment was needed in 36% of the delayed group and 2% of the simultaneous group. Clinical severity scores favored simultaneous treatment, with an early quality-of-life benefit. The clinical benefit was prolonged: the simultaneous group's Venous Clinical Severity Score was better at every review, at 6 weeks, 6 months and 1 year, and the difference held among patients who needed no further treatment. The quality-of-life benefit was early: the disease-specific score, the Aberdeen Varicose Vein Questionnaire, was 5.48 points better in the simultaneous group at 6 weeks, with no significant difference at 6 or 12 months. Patients also preferred treatment in one sitting. Of 221 eligible patients, 101 agreed to be randomized; 95% of those who declined gave wanting single-sitting treatment as their reason, and that preference kept the trial from reaching its recruitment target. The trial evaluated simultaneous phlebectomy with ablation; it did not test the complete foam phlebectomy technique described here.1
The 2023 Society for Vascular Surgery, American Venous Forum and American Vein and Lymphatic Society guideline recommends concomitant tributary treatment for symptomatic great or small saphenous reflux with associated varicosities. It allows staging for anatomical or medical reasons, with shared decision making. This supports planning the trunk and tributaries together, while leaving the choice of tributary technique to the anatomy and clinical circumstances.2
In synchronous treatment, the primary procedure is closure of the incompetent saphenous vein or veins. The varicosities are treated in the same session by ambulatory phlebectomy or by sclerotherapy. Which of the two is used depends on operator preference and experience: phlebectomy for larger, bulging varicosities, and ultrasound-guided foam sclerotherapy for smaller varicose veins or veins in areas difficult for phlebectomy. Foam phlebectomy uses both in the same session rather than choosing one.
The initial task remains identifying the source of reflux and the veins responsible for the patient's problem. Treating a visible cluster does not substitute for evaluating the venous system. A DVT examination and a reflux examination answer different questions; a report excluding DVT does not by itself establish the superficial reflux pattern.
What foam changes during phlebectomy
Foam makes the treated vein readily visible on ultrasound. If the hook cannot find a segment, the vein can be localized and the spatula end directed toward it under imaging. The hook can then engage the vein under ultrasound guidance. This is especially useful for a residual segment that is not easy to identify by palpation or through the incision.
Tumescence has a complementary role. Fluid placed around the varicosity compresses its lumen, bringing the wall closer to the foam. The aim is better wall contact with less foam. The historical series does not quantify a reduction in foam volume or establish a particular contact time.
Opening a selected vein also allows foam and blood to be expressed. My original objectives were to limit uncontrolled foam dispersion, remove intraluminal material and biologic mediators, reduce later retained coagulum and microthrombectomy, and reduce bleeding after phlebectomy. Foam expression is visible in the demonstrations. The size of any resulting reduction in systemic exposure, inflammation or thromboembolic risk was not measured in the historical series.
Two of those objectives follow from the mechanics. Expressing the foam during the phlebectomy limits the amount of foam that travels back to the heart. Decompressing the residual veins, the ones not extracted, reduces the need for microthrombectomy, because less retained blood is left in them.
Atasoy's fill-and-aspirate foam sclerotherapy report describes a related approach to foam removal in large superficial varicosities treated with endovenous laser ablation. It provides context for the idea of removing foam after treatment, rather than comparative proof of this particular method.3 Kolluri and colleagues subsequently described sclerotherapy-augmented phlebectomy using duplex guidance, tumescence and foam, including the value of treating residual vein segments.4
Planning the order of treatment
The order matters because one part of the procedure can interfere with the next. Tumescent anesthesia for endovenous ablation can compress or provoke spasm in veins that still need foam injection. Conversely, foam can obscure the ultrasound view needed to position an endovenous device.
One sequence completes endovenous ablation first: access, tumescence and treatment of the refluxing trunk. Ultrasound-guided foam sclerotherapy of the varicosities follows. The phlebectomy component then proceeds through local tumescence, foam expression and extraction.
The alternative begins with access and positioning for endovenous ablation, while the ultrasound view is clear. Foam is then injected into the varicosities, followed by tumescent placement around the tributaries, foam expression and phlebectomy. Truncal tumescence and ablation are completed afterward. This sequence preserves access before foam affects visualization and delays truncal tumescence until after foam has reached the tributaries.
Tumescent placement for truncal ablation and tumescent placement around a tributary are separate parts of that plan. Their timing must preserve access to the next treatment target.
Foam injection and distribution
The demonstrated preparation is 1% sodium tetradecyl sulfate, Sotradecol, mixed at one part sclerosant to three parts air. This remains my technique. The ultrasound-guided puncture demonstration uses a 27-gauge needle and a 3-mL syringe. Those are the tools shown in that demonstration; syringe capacity is not a statement of the total volume delivered.
The vein is identified on ultrasound and punctured under guidance. The injection demonstration shows the transition from a visible lumen to echogenic foam within it. The transducer is then used to distribute foam through the calf varicosities under ultrasound observation.
The older outcomes series recorded either 1% or 3% sodium tetradecyl sulfate with the same 1:3 air ratio. That historical entry is part of the series; it should not be read as an instruction to use 3% for every vein. Concentration, total sclerosant dose, foam volume and the patient's risk profile remain separate treatment decisions. This technical description does not specify a universal total dose or a complete perioperative protocol.
Tumescence and foam expression
Ultrasound guides tumescent placement around the selected varicosities. In the foam-expression demonstration, tumescence is initially limited to the area where phlebectomy is planned. The vein is entered through a small puncture, and manual compression expresses the foam and blood.
A 14-gauge needle makes the elliptical opening shown here. One clip shows the opening and expression in a few seconds; another shows expression from an anterior shin varicosity. These are intraprocedural maneuvers performed after foam injection. They are different from returning weeks later to evacuate retained coagulum.
Decompressing a vein does not establish that all foam has been recovered or that thromboembolic risk has been eliminated. The later DVT and pulmonary embolism in the historical series make that distinction clinically important.
Choosing the opening and the hook
The original technique separates two practical approaches around a vein diameter of approximately 4 mm. That is a description of instrument selection, not a validated cutoff that determines treatment by itself.
| Target vein | Opening and instrument | How the vein is engaged | Practical tradeoff described |
|---|---|---|---|
| Smaller varicosities, approximately 4 mm and below | Elliptical opening with a 14-gauge needle; Varady FB2 hook | Engage a single wall and exteriorize it | Smaller wound and faster healing; the dissection is tedious, slower and more deliberate |
| Larger varicosities, approximately 4 mm and above | Opening with a No. 11 blade; Varady FB1 hook | Engage a single wall or the whole vein | Faster procedure and extraction, with a larger opening that takes longer to heal |
Once a wall has been exteriorized, it is grasped with forceps. The spatula end of the hook frees the vein from the surrounding tissue, and the grasp advances as more vein is exposed. The demonstration is a sequence of dissection and controlled extraction, rather than simply pulling on the first segment that appears.
When a loop is exteriorized, both ends can be worked to increase the length removed through that opening. If a segment is difficult to locate, ultrasound provides a way to find it and direct the instrument. The smaller branches reached by foam do not all require mechanical extraction, although persistent symptomatic veins still require follow-up assessment.
Technical examples by location
The demonstrations below follow the opening, engagement and dissection of the selected vein. They show how the same principles are applied in different anatomical locations.
Anterior thigh
The anterior thigh example shows the 14-gauge elliptical opening, blunt dissection with the spatula, engagement of a single vein wall with the FB2 hook, and grasping of the exteriorized segment. Progressive dissection exposes additional vein so that the grasp can advance. This is the clearest complete introduction to the small-hook technique.
Anterior shin
The shin example uses the same small opening and FB2 hook. The teaching point is exteriorizing one wall and progressively freeing the vein with the spatula. The phlebectomy segment begins after puncture and foam expression; those earlier actions are shown separately.
Popliteal fossa
The varicosities are marked with the patient standing. The original example uses 1% Sotradecol foam and 14-gauge elliptical openings. An access clip is followed by a longer dissection clip showing single-wall engagement, progressive release with the spatula and forceps control of the exposed vein. Together the two clips show the transition from opening the skin to extracting the vein.
Medial calf
The medial calf demonstration uses the FB2 hook to engage and exteriorize one wall. After forceps grasp the vein, dissection continues until a loop can be exposed. Working both ends of that loop is the central teaching point. The clip continues through the completion of the maneuver and the final appearance of the openings.
Larger calf varicosities
The FB1 demonstration shows a loop of vein being exteriorized. Each end is then dissected free and removed. It gives the reader a comparison with the smaller-hook examples without implying that the two instruments are interchangeable in every situation.
Extrafascial continuation of the great saphenous vein
The tributary example concerns an extrafascial continuation of the great saphenous vein. Foam is used, and ultrasound identifies the tributary and guides tumescent placement and the openings. In this example, sequential phlebectomy with the FB1 hook proceeds from cranial to caudal, and the extrafascial segment is removed intact.
The technical point is the relationship between successive openings and the vein being freed between them. Following the segment from one opening to the next shows how controlled sequential dissection can preserve continuity during extraction.
The longer demonstration is divided into four consecutive chapters at instrument and position changes. Together they show the complete sequence. Watch the continuous demonstration (7:23).
What the historical experience taught
My early experience combined great or small saphenous laser ablation with foam phlebectomy and follow-up through three months. The technical description included 4 to 33 phlebectomy incisions, with a mean of 13.5, and ultrasound-guided foam using 1% or 3% Sotradecol mixed 1:3 with air. My current demonstrated preparation remains 1%.
| Assessment | Clinical findings and subsequent care |
|---|---|
| One week | Endovenous heat-induced thrombosis was reported as requiring no treatment; infections required treatment. No DVT or pulmonary embolism was recorded at that visit, and no bleeding-related phone calls or returns to clinic were reported. |
| Three to five weeks | Retained coagulum prompted microthrombectomy for discomfort or discoloration. DVT with pulmonary embolism occurred after a negative one-week ultrasound. |
| Three months | Great saphenous recanalization longer than 5 cm occurred and was sometimes symptomatic. Further treatment included repeat laser ablation and foam treatment for residual symptomatic varicose veins. |
In the broader practice at that time, synchronous treatment was common and foam phlebectomy was frequently used. The practice summary reported no returns for bleeding after phlebectomy and no cosmetic or wound-healing problems; unplanned treatment, usually foam, was sometimes needed. Those broad observations must be read alongside the infections, microthrombectomies and thromboembolic event in the detailed follow-up. They describe different aspects of the experience and do not establish a complication-free procedure.
This experience demonstrates feasibility, the range of treatment performed and the follow-up problems encountered. It was not an independently adjudicated comparative study, and completeness of follow-up was not established. Without a comparison group, it cannot show that foam phlebectomy reduced bleeding, infection, pigmentation, microthrombectomy or total cost relative to either component alone. Combining the initial procedures did not remove the need for subsequent care.
Follow-up and microthrombectomy
Clinical follow-up asks whether symptoms have improved, whether the wounds have healed, whether residual veins remain symptomatic and whether retained coagulum is causing discomfort or discoloration. The photographs below show the typical result at follow-up: in each pair, the bulging varicosities seen before treatment (left) are gone afterward (right), while finer veins remain. The photographs illustrate appearance; they do not by themselves establish the interval or a cosmetic success rate.
My indication for microthrombectomy is symptoms or skin discoloration. This is a targeted response to the treated vein and its contents, rather than an automatic additional procedure for every patient. The companion brief, Microthrombectomy after sclerotherapy, explains the assessment and the distinction between evacuable clot and established pigmentation.
New symptoms after treatment require their own assessment. A previous normal ultrasound does not exclude a later event. Current guidance recommends early duplex evaluation in patients with symptoms after thermal or nonthermal ablation to exclude ablation-related thrombus extension or DVT.2
Foam phlebectomy works as a technical approach because each part has a purpose: foam reaches the network and improves ultrasound visibility, tumescence compresses and anesthetizes the operative field, expression decompresses selected veins, and phlebectomy removes the segments best treated by extraction. The clinical work continues through follow-up, including microthrombectomy when symptoms or discoloration justify it.
References
- Lane TRA, Kelleher D, Shepherd AC, Franklin IJ, Davies AH. Ambulatory varicosity avulsion later or synchronized (AVULS): a randomized clinical trial. Ann Surg. 2015;261(4):654–661. doi
- Gloviczki P, Lawrence PF, Wasan SM, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. doi
- Atasoy MM. Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein. Clin Radiol. 2015;70(1):48–53. doi
- Kolluri R, Hays KU, Gohel MS. Foam sclerotherapy augmented phlebectomy (SAP) procedure for varicose veins: report of a novel technique. EJVES Short Rep. 2018;41:16–18. doi